SCHEMBL10098467

SCHEMBL10098467

CC(C)CC(N)CCC(N)=O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PMP22 Q01453 2/20 0.46
ALOX15 P16050 1/20 0.46
BLM P54132 1/20 0.46
KMT2A Q03164 1/20 0.46
SLC7A5 Q01650 1/20 0.43
DPP4 P27487 1/20 0.42
DPP8 Q6V1X1 1/20 0.42
DPP9 Q86TI2 1/20 0.42
ANPEP P15144 6/20 0.41
ERAP1 Q9NZ08 2/20 0.41
ERAP2 Q6P179 1/20 0.41
TSHR P16473 2/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2D6 P10635 1/20 0.39
NFKB1 P19838 1/20 0.39
THPO P40225 1/20 0.39
FOLH1 Q04609 1/20 0.38
GABRP O00591 2/20 0.38
GABRD O14764 2/20 0.38
GABRA1 P14867 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16103400 1.00 PMP22 (0.46) PMP22ALOX15BLMKMT2ASLC7A5
SCHEMBL18822349 1.00 PMP22 (0.46) PMP22ALOX15BLMKMT2ASLC7A5
SCHEMBL18822642 0.82 GABRP (0.60) BLMKMT2ASLC7A5ANPEPTSHR
SCHEMBL288675 0.82 GABRP (0.60) BLMKMT2ASLC7A5ANPEPTSHR
SCHEMBL1123027 0.82 GABRP (0.60) BLMKMT2ASLC7A5ANPEPTSHR
Hydrochloric Acid SCHEMBL9129209 0.80 GABRP (0.58) PMP22BLMKMT2ASLC7A5ANPEP
SCHEMBL30530245 0.80 ALOX15 (0.59) PMP22ALOX15BLMKMT2ADPP4
SCHEMBL12000789 0.79 ALOX15 (0.43) PMP22ALOX15BLMKMT2ASLC7A5
SCHEMBL28286461 0.79 CACNA2D1 (0.43) PMP22ALOX15BLMKMT2ASLC7A5
SCHEMBL105245 0.78

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8841257-B2 Inhibitors of STAT3 and uses thereof BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) 2014-09-23 US disclosed
US-20120035114-A1 INHIBITORS OF STAT3 AND USES THEREOF BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) 2012-02-09 US disclosed
US-20120035114-A1 INHIBITORS OF STAT3 AND USES THEREOF BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) 2012-02-09 US disclosed
WO-2010118309-A2 INHIBITORS OF STAT3 AND USES THEREOF BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) 2010-10-14 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120035114-A1 INHIBITORS OF STAT3 AND USES THEREOF STAT3, JAK2, STAT6 PMP22 4478/4885ALOX15 2409/4885BLM 3718/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.